Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence, the company has enhanced the recovery potential of patients with neurological diseases.

Combining FDA-cleared and CE-marked digital therapeutics with best-in-class motion analytics, AI, and cloud technologies, MindMaze aims to create a universal platform for brain health.

MindMaze Labs, the company's enterprising R&D division, brings groundbreaking neuroscience to everyday life. They harness the power of the brain to empower the next generation of human-machine interfaces.

MindMaze provides evidence-driven therapy and assessment portfolios powered by medical-grade software, tailored interactive content, and proprietary peripherals. Their solutions focus on neurorehabilitation through digital therapeutics, enabling restoration of motor, cognitive, and cardiovascular function following neural injuries and degeneration.

The company's digital therapies and teleneurorehabilitation platforms, such as MindMotion GO, help neurological patients access therapy safely from home, impacting lives globally through partnerships with leading medical and research institutions.

MindMaze is recognized as a pioneer in neurodigital therapeutics with numerous regulatory approvals, patents, and scientific publications supporting their innovative approach.